Veeva Systems is a cloud-computing company that provides software solutions for the life sciences industry. It has been one of the top-performing tech stocks over the past year, with its shares rising by more than 60%.
One of the technical indicators that traders use to gauge the momentum of a stock is the Relative Strength Index (RSI). The 10-day RSI Oscillator for VEEV moved out of overbought territory on February 03, 2023. An overbought condition occurs when the RSI is above 70, which suggests that the stock has risen too far, too fast and is due for a pullback. A move out of overbought territory can be a sign that the stock is shifting from an upward trend to a downward trend.
According to Tickeron's A.I.dvisor, which uses artificial intelligence to analyze stocks, there have been 43 instances where the RSI for VEEV moved out of the overbought zone. In 31 of those instances, the stock moved lower in the days that followed, which puts the odds of a move down at 72%. This suggests that traders may want to consider selling the stock or buying put options to profit from a potential decline in the stock's price.
In addition to technical indicators, it is also important to consider the company's earnings reports. Veeva Systems reported its Q3 2022 earnings on November 30, 2022. The company reported revenue of $502.9 million, up 35% year-over-year, and non-GAAP earnings per share of $0.89, up 27% year-over-year. The company also raised its full-year revenue guidance.
However, the stock price did not react positively to the earnings report. In fact, the stock price fell by more than 5% in the days following the report.
It's crucial to take both technical analysis and fundamental analysis into account when evaluating equities. Technical analysis can shed light on a stock's momentum, whereas fundamental analysis can shed light on the company's true worth. While the most recent earnings report indicates that Veeva Systems is doing well, technical analysis implies that the stock may be due for a pullback.
On January 08, 2025, the Stochastic Oscillator for VEEV moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 52 instances where the indicator left the oversold zone. In of the 52 cases the stock moved higher in the following days. This puts the odds of a move higher at over .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where VEEV advanced for three days, in of 298 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Momentum Indicator moved below the 0 level on December 16, 2024. You may want to consider selling the stock, shorting the stock, or exploring put options on VEEV as a result. In of 79 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
VEEV moved below its 50-day moving average on December 24, 2024 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for VEEV crossed bearishly below the 50-day moving average on December 27, 2024. This indicates that the trend has shifted lower and could be considered a sell signal. In of 13 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where VEEV declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Aroon Indicator for VEEV entered a downward trend on January 08, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. VEEV’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 87, placing this stock slightly better than average.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (8.000) is normal, around the industry mean (31.338). P/E Ratio (71.550) is within average values for comparable stocks, (158.237). Projected Growth (PEG Ratio) (1.505) is also within normal values, averaging (2.763). Dividend Yield (0.000) settles around the average of (0.084) among similar stocks. P/S Ratio (15.924) is also within normal values, averaging (58.727).
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a provider of industry-specific, cloud-based software solutions for the life sciences industry
Industry PackagedSoftware